×
For best experience we recommend to activate Javascript in your browser.
CSNK2A1/CK II alpha antibody (AA 14-337)
This anti-CSNK2A1/CK II alpha antibody is a Rabbit Polyclonal antibody detecting CSNK2A1/CK II alpha in WB and ELISA. Suitable for Human.
Quick Overview for CSNK2A1/CK II alpha antibody (AA 14-337) (ABIN7568461)
Target
See all CSNK2A1/CK II alpha (CSNK2A1) Antibodies
CSNK2A1/CK II alpha (CSNK2A1)
(Casein Kinase 2 alpha 1 (CSNK2A1))
Reactivity
All reactivities for CSNK2A1/CK II alpha antibodies
Human
Host
All hosts for CSNK2A1/CK II alpha antibodies
Rabbit
Clonality
All clonalities for CSNK2A1/CK II alpha antibodies
Polyclonal
Conjugate
All conjugates for CSNK2A1/CK II alpha antibodies
This CSNK2A1/CK II alpha antibody is un-conjugated
Application
All applications for CSNK2A1/CK II alpha antibodies
Western Blotting (WB), ELISA
Product Details anti-CSNK2A1/CK II alpha Antibody
(hide)
Binding Specificity
All epitopes for CSNK2A1/CK II alpha antibodies
AA 14-337
Purpose
Anti-Human CSNK2A1/CK2A1 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human CSNK2A1/CK2A1 (Asp14-Ser337).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for CSNK2A1/CK II alpha
(hide)
Target
CSNK2A1/CK II alpha (CSNK2A1)
(Casein Kinase 2 alpha 1 (CSNK2A1))
Alternative Name
CSNK2A1
Background
CSNK2A1, CK II alpha, CK2A1, Casein kinase II subunit alpha
Pathways
SARS-CoV-2 Protein Interactome
Recently viewed
(hide)
Chat with us , powered by LiveChat